Trial intelligence / Profile preview

Roflumilast cream in chronic plaque psoriasis

NCT04211363Phase 3Completed

Sponsor
Arcutis Biotherapeutics
Start
Dec 2019
Primary completion
Nov 2020
Countries
2
01

Overview

A Phase 3 trial of roflumilast vehicle cream in psoriasis, sponsored by Arcutis Biotherapeutics. Started Dec 2019; status: completed.

02

Drugs

roflumilast vehicle cream
03

Conditions

psoriasis

Beyond the preview

Go deeper on NCT04211363.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04211363.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call